Cargando…
Acetyltransferase p300 Is a Putative Epidrug Target for Amelioration of Cellular Aging-Related Cardiovascular Disease
Cardiovascular disease is the leading cause of accelerated as well as chronological aging-related human morbidity and mortality worldwide. Genetic, immunologic, unhealthy lifestyles including daily consumption of high-carb/high-fat fast food, lack of exercise, drug addiction, cigarette smoke, alcoho...
Autor principal: | Ghosh, Asish K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616404/ https://www.ncbi.nlm.nih.gov/pubmed/34831061 http://dx.doi.org/10.3390/cells10112839 |
Ejemplares similares
-
A novel acetyltransferase p300 inhibitor ameliorates hypertension-associated cardio-renal fibrosis
por: Rai, Rahul, et al.
Publicado: (2017) -
Acetyltransferase p300 inhibitor reverses hypertension‐induced cardiac fibrosis
por: Rai, Rahul, et al.
Publicado: (2019) -
p300 in Cardiac Development and Accelerated Cardiac Aging
por: Ghosh, Asish K
Publicado: (2020) -
Diabetes and Its Cardiovascular Complications: Potential Role of the Acetyltransferase p300
por: Di Pietrantonio, Nadia, et al.
Publicado: (2023) -
Epidrugs: Toward Understanding and Treating Diverse Diseases
por: Umehara, Takashi
Publicado: (2022)